Greenlam Industries Ltd. - Research Center
538979 GRNLAMIND Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 21 | Sep ' 20 | Sep ' 19 | Sep ' 18 | Sep ' 17 | |
|---|---|---|---|---|---|
| Sales | 729.41 | 414.06 | 594.76 | 557.97 | 514.08 |
| Operating profit | 73.60 | 46.56 | 71.66 | 59.07 | 65.30 |
| Interest | 6.38 | 9.06 | 10.44 | 8.26 | 8.23 |
| Gross profit | 75.00 | 39.42 | 69.64 | 51.42 | 58.01 |
| EPS (Rs) | 15.17 | 4.59 | 16.30 | 10.15 | 11.17 |
Half yearly
results in details
| Sep ' 21 | Sep ' 20 | Sep ' 19 | Sep ' 18 | Sep ' 17 | |
|---|---|---|---|---|---|
| Other income | 7.77 | 1.92 | 8.42 | 0.61 | 0.95 |
| Stock adjustment | -20.11 | 1.65 | -35.43 | -14.35 | -12.41 |
| Raw material | 442.19 | 218.02 | 354.29 | 329.22 | 289.89 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 102.28 | 69.30 | 88.19 | 77.10 | 68.37 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 131.46 | 78.52 | 116.05 | 106.91 | 102.93 |
| Provisions made | - | - | - | - | - |
| Depreciation | 26.63 | 25.63 | 23.40 | 16.86 | 16.14 |
| Taxation | 9.15 | 2.72 | 6.89 | 10.07 | 14.91 |
| Net profit / loss | 36.62 | 11.07 | 39.35 | 24.49 | 26.97 |
| Extra ordinary item | -2.59 | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 12.07 | 12.07 | 12.07 | 12.07 | 12.07 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 10.09 | 11.25 | 12.05 | 10.59 | 12.70 |
| GPM (%) | 10.17 | 9.48 | 11.55 | 9.21 | 11.26 |
| NPM (%) | 4.97 | 2.66 | 6.52 | 4.38 | 5.24 |
Mutual Fund Selector
Find the fund that is right for you
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis